India's Morepen secures approval of anti-allergy API Loratadine for export to China
Overview
India-based Morepen Laboratories, a global leader in Active Pharmaceutical Ingredient (API) manufacturing, has received approval from the Center for Drug Evaluation (CDE) of the National Medical Products Administration (NMPA) in China for its Loratadine (anti-allergy API). This marks a significant milestone in Morepen’s strategic entry into one of the world’s largest pharmaceutical markets.
The market shares for Loratadine in US
• Morepen commands an over 80% market share in the US generics market for Loratadine, making it the undisputed leader in its category.
• The company has been exporting to the US market for over 25 years, its API exports alone are valued at Rs 650 crore.
Morepen Strengthens Global Leadership in Loratadine Market
• Approval reinforces Morepen’s dominance as a leading global manufacturer of Loratadine.
• Loratadine, a second-generation antihistamine, is widely used for hay fever & chronic urticaria.
• The development positions Morepen to capture a significant share of the Chinese market.
• Enhances Morepen’s global presence in the pharmaceutical sector.
Statement from Kushal Suri from Morepen Laboratories
Kushal Suri, Director – Sales & Marketing, Morepen Laboratories said, “China represents a vast growth opportunity, and this milestone will allow us to meet the increasing demand for high-quality antihistamine and anti-allergy APIs while reinforcing our leadership in global healthcare.”
Morepen’s API exporter
• Morepen is a leading APIs exporter out of India for six leading products, including Loratadine, Montelukast, Desloratadine, Atorvastatin, Rosuvastatin, and Fexofenadine.
• The company exports to 82 countries and has a manufacturing capacity of 144 metric tons API annually.
Let’s apply Data-Driven Pricing to Your APIs
Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.
Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.
Start using market intelligence today and allow yourself to be in control in the API market.
Check it out today and make more informed sourcing decisions!
Learn More!